Pharma R&D Today
Ideas and Insight supporting all stages of Drug Discovery & Development
As The Hive Evolves, More Companies Prepare to Join the Program
Posted on December 11th, 2017 by Betsy Davis in Pharma R&D
This year, four companies working in early-stage drug development were able to power their efforts with an array of Elsevier tools by participating in The Hive. Now, more promising pharma and biotech start-ups are in the process of entering into The Hive (more…)
Extreme Makeover: Clinical Trials Edition
Posted on December 4th, 2017 by Sherry Winter in Pharma R&D
In a piece featured in the PharmaTimes, Katrina Megget points out the sad state of affairs when it comes to clinical trials, highlighting some appalling stats on the frequent failure to reach enrollment targets (in some cases, not finding any patients at all) and the tendency for studies to go on far longer than anticipated. (more…)
Re-Inventing R&D for Precision Medicine
Posted on May 22nd, 2017 by Betsy Davis in Pharma R&D
Precision medicine first emerged in the late ‘90s. But it was the completion of the Human Genome Project in 2003 that really opened up a world of opportunity in this area because it became possible to test patients for certain biomarkers (more…)
How Are You Handling Big Data & Innovation?
Posted on April 28th, 2017 by Betsy Davis in Pharma R&D
Although every pharmaceutical company still hopes to find the next blockbuster drug, today’s R&D departments are becoming increasingly focused on developing more targeted therapies. It is the advent of Big Data that has made it possible for researchers to advance precision medicine and targeted drugs (more…)
